Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2012

01-09-2012 | Original Article

Surgical Outcomes and Predicting Factors of Curative Resection in Patients with Hilar Cholangiocarcinoma: 10-Year Single-Institution Experience

Authors: Min Soo Cho, Sung Hoon Kim, Seung Woo Park, Jin Hong Lim, Gi Hong Choi, Joon Seong Park, Jae Bock Chung, Kyung Sik Kim

Published in: Journal of Gastrointestinal Surgery | Issue 9/2012

Login to get access

Abstract

Background

The surgical resection of hilar cholangiocarcinoma is extremely challenging because the tumor is closely related with the complicated hilar structures. We investigated to identify the outcomes for patients who underwent surgical resection and to identify the parameters that influenced radical resection.

Methods

From January 2000 to December 2009, 105 patients underwent surgical resection for hilar cholangiocarcinoma. The clinicopathological parameters and surgical outcomes were retrospectively analyzed.

Results

There were 15 operative mortalities (14.3%). Seventy-four patients underwent curative resection (70.5%). The median overall survival time for R0, R1, and R2 were 58, 28, and 19 months, respectively. Caudate lobectomy (p = 0.044; odds ratio [OR], 4.386) and perineural invasion (p = 0.01; OR, 0.062) were correlated with curative resection. Total bilirubin levels of more than 3 g/dl just before the operation (p = 0.042; hazard ratio [HR], 2.109) and extent of resection (R1 and 2 vs R0; p = 0.05; HR, 2.309) were selected as significantly negative factors affecting overall survival on the multivariate analysis.

Conclusions

Caudate lobectomy and neurectomy may be thought of as adjustable territories by the surgeon’s efforts to achieve curative resection. R0 resection achieved through those efforts and liver optimization using preoperative biliary drainage may offer the patients a chance of cure.
Literature
1.
go back to reference Altemeier WA, Gall EA, Culbertson WR, Inge WW. Sclerosing carcinoma of the intrahepatic (hilar) bile ducts. Surgery 1966;60(1):191-200. Altemeier WA, Gall EA, Culbertson WR, Inge WW. Sclerosing carcinoma of the intrahepatic (hilar) bile ducts. Surgery 1966;60(1):191-200.
2.
go back to reference Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. The American Journal of Medicine 1965;38(2):241-256.PubMedCrossRef Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. The American Journal of Medicine 1965;38(2):241-256.PubMedCrossRef
3.
go back to reference Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease 2010;42(7):490-495.PubMedCrossRef Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease 2010;42(7):490-495.PubMedCrossRef
4.
go back to reference Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006;98(12):873-875.PubMedCrossRef Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006;98(12):873-875.PubMedCrossRef
5.
go back to reference Lau SHY, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary and Pancreatic Diseases International 2012;11(1):12-17.PubMedCrossRef Lau SHY, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary and Pancreatic Diseases International 2012;11(1):12-17.PubMedCrossRef
6.
go back to reference Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. Journal of Hepato-Biliary-Pancreatic Surgery 2010;17(4):449-454. Igami T, Nishio H, Ebata T, et al. Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience. Journal of Hepato-Biliary-Pancreatic Surgery 2010;17(4):449-454.
7.
go back to reference Miyazaki M, Kimura F, Shimizu H, et al. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. Journal of Hepato-Biliary-Pancreatic Surgery 2007;14(5):463-468.PubMedCrossRef Miyazaki M, Kimura F, Shimizu H, et al. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection. Journal of Hepato-Biliary-Pancreatic Surgery 2007;14(5):463-468.PubMedCrossRef
8.
go back to reference Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Annals of Surgery 2009;250(2):210-218.PubMedCrossRef Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Annals of Surgery 2009;250(2):210-218.PubMedCrossRef
9.
go back to reference Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. Journal of Gastroenterology 2011; 46:242-248. Kawakami H, Kuwatani M, Onodera M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. Journal of Gastroenterology 2011; 46:242-248.
10.
go back to reference Chung MJ, Lee KJ, Bang S, et al. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. Annals of Surgical Oncology 2011;18(6):1651-1656.PubMedCrossRef Chung MJ, Lee KJ, Bang S, et al. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. Annals of Surgical Oncology 2011;18(6):1651-1656.PubMedCrossRef
11.
go back to reference Hong YK, Choi SB, Lee KH, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. European Journal of Surgical Oncology (EJSO) 2011;37(3):237-244.CrossRef Hong YK, Choi SB, Lee KH, et al. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: a retrospective cohort study. European Journal of Surgical Oncology (EJSO) 2011;37(3):237-244.CrossRef
12.
go back to reference Sano T, Kamiya J, Nagino M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. Journal of Hepato-Biliary-Pancreatic Surgery 1999;6(2):101-107.PubMedCrossRef Sano T, Kamiya J, Nagino M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. Journal of Hepato-Biliary-Pancreatic Surgery 1999;6(2):101-107.PubMedCrossRef
13.
go back to reference Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998;123(2):131-136.PubMedCrossRef Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 1998;123(2):131-136.PubMedCrossRef
14.
go back to reference Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, Van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Annals of Surgical Oncology 2006;13(6):872-880.PubMedCrossRef Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, Van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Annals of Surgical Oncology 2006;13(6):872-880.PubMedCrossRef
15.
go back to reference Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Annals of Surgery 2008;248(2):273-279.PubMedCrossRef Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Annals of Surgery 2008;248(2):273-279.PubMedCrossRef
16.
go back to reference Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Annals of Surgery 2003;238(5):720-727.PubMedCrossRef Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Annals of Surgery 2003;238(5):720-727.PubMedCrossRef
17.
go back to reference Dinant S, Gerhards MF, Busch ORC, Obertop H, Gouma DJ, Van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB 2005;7(4):263-267.PubMedCrossRef Dinant S, Gerhards MF, Busch ORC, Obertop H, Gouma DJ, Van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB 2005;7(4):263-267.PubMedCrossRef
18.
go back to reference Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. British Journal of Surgery 2006;93(12):1488-1494.PubMedCrossRef Liu CL, Fan ST, Lo CM, Tso WK, Lam CM, Wong J. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. British Journal of Surgery 2006;93(12):1488-1494.PubMedCrossRef
19.
go back to reference Ercolani G, Zanello M, Grazi GL, et al. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17(3):329-337.PubMedCrossRef Ercolani G, Zanello M, Grazi GL, et al. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17(3):329-337.PubMedCrossRef
20.
go back to reference Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Annals of Surgery 2007;246(6):1052-1057.PubMedCrossRef Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y. Surgical approach to Bismuth type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Annals of Surgery 2007;246(6):1052-1057.PubMedCrossRef
21.
go back to reference Figueras J, Codina-Barreras A, López-Ben S, et al. Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice. Las hepatectomías mayores en pacientes con colangiocarcinoma e ictericia son seguras 2009;86(5):296-302. Figueras J, Codina-Barreras A, López-Ben S, et al. Major hepatectomies are safe in patients with cholangiocarcinoma and jaundice. Las hepatectomías mayores en pacientes con colangiocarcinoma e ictericia son seguras 2009;86(5):296-302.
22.
go back to reference Nagino M, Takada T, Miyazaki M, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. Journal of Hepato-Biliary-Pancreatic Surgery 2008;15(1):25-30.PubMedCrossRef Nagino M, Takada T, Miyazaki M, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. Journal of Hepato-Biliary-Pancreatic Surgery 2008;15(1):25-30.PubMedCrossRef
23.
go back to reference Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepato-Gastroenterology 2006;53(67):5-10.PubMed Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepato-Gastroenterology 2006;53(67):5-10.PubMed
24.
go back to reference Grandadam S, Compagnon P, Arnaud A, et al. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Annals of Surgical Oncology 2010; 17(12). Grandadam S, Compagnon P, Arnaud A, et al. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Annals of Surgical Oncology 2010; 17(12).
25.
go back to reference Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. Journal of Hepato-Biliary-Pancreatic Surgery 2010;17(4):455-462 Hirano S, Kondo S, Tanaka E, et al. Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. Journal of Hepato-Biliary-Pancreatic Surgery 2010;17(4):455-462
26.
go back to reference Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Annals of Surgery 2006;243(3):364-372.PubMedCrossRef Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Annals of Surgery 2006;243(3):364-372.PubMedCrossRef
27.
go back to reference Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa SI. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Annals of Surgery 2003;238(1):84-92.PubMed Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa SI. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Annals of Surgery 2003;238(1):84-92.PubMed
28.
go back to reference Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Annals of Surgery 2003;238(1):73-83.PubMed Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Annals of Surgery 2003;238(1):73-83.PubMed
29.
go back to reference Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European Journal of Surgical Oncology 2008;34(7):787-794.PubMedCrossRef Hidalgo E, Asthana S, Nishio H, et al. Surgery for hilar cholangiocarcinoma: the Leeds experience. European Journal of Surgical Oncology 2008;34(7):787-794.PubMedCrossRef
30.
go back to reference Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. British Journal of Cancer 2009;100(4):617-622.PubMedCrossRef Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. British Journal of Cancer 2009;100(4):617-622.PubMedCrossRef
31.
go back to reference De Graaf W, Van Den Esschert JW, Van Lienden KP, Van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Annals of Surgical Oncology 2009;16(2):423-430.PubMedCrossRef De Graaf W, Van Den Esschert JW, Van Lienden KP, Van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Annals of Surgical Oncology 2009;16(2):423-430.PubMedCrossRef
Metadata
Title
Surgical Outcomes and Predicting Factors of Curative Resection in Patients with Hilar Cholangiocarcinoma: 10-Year Single-Institution Experience
Authors
Min Soo Cho
Sung Hoon Kim
Seung Woo Park
Jin Hong Lim
Gi Hong Choi
Joon Seong Park
Jae Bock Chung
Kyung Sik Kim
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 9/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-1960-0

Other articles of this Issue 9/2012

Journal of Gastrointestinal Surgery 9/2012 Go to the issue